Home › Employers › Versatope Therapeutics, Inc.
Versatope Therapeutics, Inc.: H-1B salaries and sponsorship
Versatope Therapeutics, Inc. filed 5 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 5. Median offered salary: $73,278.
Does Versatope Therapeutics, Inc. sponsor H-1B visas?
Versatope Therapeutics, Inc. filed 5 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 15, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Scientist | 3 | $77,615 |
| Scientist I | 2 | $68,400 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 3 | $76,086 |
| FY2026 | 2 | $70,470 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Scientist I | $70,470 Level I | Lowell, MA | Mar 15, 2026 | Mar 15, 2026 | Certified |
| Scientist | $86,299 part-time · Level I | Lowell, MA | Mar 15, 2026 | Mar 15, 2026 | Certified |
| Scientist | $79,144 Level I | Lowell, MA | Jun 11, 2025 | Oct 1, 2025 | Certified |
| Scientist I | $66,331 Level I | Lowell, MA | May 8, 2025 | Oct 1, 2025 | Certified |
| Scientist | $76,086 Level I | Lowell, MA | May 8, 2025 | Oct 1, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).